DE3372176D1 - Apparatus for use in stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders - Google Patents

Apparatus for use in stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders

Info

Publication number
DE3372176D1
DE3372176D1 DE8383102082T DE3372176T DE3372176D1 DE 3372176 D1 DE3372176 D1 DE 3372176D1 DE 8383102082 T DE8383102082 T DE 8383102082T DE 3372176 T DE3372176 T DE 3372176T DE 3372176 D1 DE3372176 D1 DE 3372176D1
Authority
DE
Germany
Prior art keywords
disclosed
emulsion
nutrient
component
nutrient emulsion
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
DE8383102082T
Other languages
English (en)
Inventor
Jewell L Osterholm
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Thomas Jefferson University
Original Assignee
Thomas Jefferson University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomas Jefferson University filed Critical Thomas Jefferson University
Application granted granted Critical
Publication of DE3372176D1 publication Critical patent/DE3372176D1/de
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0026—Blood substitute; Oxygen transporting formulations; Plasma extender
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/02—Halogenated hydrocarbons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0029—Parenteral nutrition; Parenteral nutrition compositions as drug carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M3/00—Medical syringes, e.g. enemata; Irrigators
    • A61M3/02—Enemata; Irrigators
    • A61M3/0204—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity
    • A61M3/0212—Physical characteristics of the irrigation fluid, e.g. conductivity or turbidity after use
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M25/00—Catheters; Hollow probes
    • A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
    • A61M25/02—Holding devices, e.g. on the body
    • A61M2025/028—Holding devices, e.g. on the body having a mainly rigid support structure
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0464—Cerebrospinal fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2202/00—Special media to be introduced, removed or treated
    • A61M2202/04—Liquids
    • A61M2202/0468—Liquids non-physiological
    • A61M2202/0476—Oxygenated solutions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2205/00—General characteristics of the apparatus
    • A61M2205/36—General characteristics of the apparatus related to heating or cooling
    • A61M2205/3653—General characteristics of the apparatus related to heating or cooling by Joule effect, i.e. electric resistance
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
    • A61M2210/00—Anatomical parts of the body
    • A61M2210/06—Head
    • A61M2210/0693—Brain, cerebrum
DE8383102082T 1982-03-03 1983-03-03 Apparatus for use in stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders Expired DE3372176D1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/354,346 US4445886A (en) 1980-04-14 1982-03-03 Stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders

Publications (1)

Publication Number Publication Date
DE3372176D1 true DE3372176D1 (en) 1987-07-30

Family

ID=23392905

Family Applications (1)

Application Number Title Priority Date Filing Date
DE8383102082T Expired DE3372176D1 (en) 1982-03-03 1983-03-03 Apparatus for use in stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders

Country Status (6)

Country Link
US (1) US4445886A (de)
EP (1) EP0088954B1 (de)
JP (1) JPS58185163A (de)
AT (1) ATE27917T1 (de)
CA (1) CA1188944A (de)
DE (1) DE3372176D1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4830849A (en) * 1980-04-14 1989-05-16 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
US4795423A (en) * 1980-04-14 1989-01-03 Thomas Jefferson University Oxygenated perfluorinated perfusion of the ocular globe to treat ischemic retinopathy
US4657532A (en) * 1985-07-19 1987-04-14 Thomas Jefferson University Intra-peritoneal perfusion of oxygenated fluorocarbon
US4840617A (en) * 1980-04-14 1989-06-20 Thomas Jefferson University Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
US4494285A (en) * 1982-08-16 1985-01-22 Windsor Medical, Inc. Method of making a member defining a lumen for a peristaltic pump and member produced by said method
EP0212213B1 (de) * 1985-07-16 1991-05-29 Thomas Jefferson University Gerät zur zerebralen Katheterisierung
GB8522374D0 (en) * 1985-09-10 1985-10-16 Univ Jefferson Oxygenated perfluorinated perfusion treatment
JPH0410845Y2 (de) * 1987-06-18 1992-03-17
DE4102843C1 (de) * 1991-01-31 1992-05-27 Fresenius Ag, 6380 Bad Homburg, De
US6344489B1 (en) * 1991-02-14 2002-02-05 Wayne State University Stabilized gas-enriched and gas-supersaturated liquids
US5350359A (en) * 1992-07-16 1994-09-27 Temple University Of The Commonwealth System Of Higher Education Control, treatment and/or diagnosis of physiological conditions with degassed perfluorocarbon liquid
US5335650A (en) * 1992-10-13 1994-08-09 Temple University - Of The Commonwealth System Of Higher Education Process control for liquid ventilation and related procedures
US6110168A (en) * 1993-02-10 2000-08-29 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modifications
US6033383A (en) * 1996-12-19 2000-03-07 Ginsburg; Robert Temperature regulating catheter and methods
US6620188B1 (en) 1998-08-24 2003-09-16 Radiant Medical, Inc. Methods and apparatus for regional and whole body temperature modification
US5837003A (en) * 1993-02-10 1998-11-17 Radiant Medical, Inc. Method and apparatus for controlling a patient's body temperature by in situ blood temperature modification
US6849083B2 (en) * 1993-02-10 2005-02-01 Radiant Medical, Inc. Method and apparatus for controlling a patients's body temperature by in situ blood temperature modification
US5810759A (en) * 1997-03-27 1998-09-22 Michigan Critical Care Consultants, Inc. Control system for regulating gas exchange in extracoporeal circulation
US6030358A (en) * 1997-08-08 2000-02-29 Odland; Rick Matthew Microcatheter and method for site specific therapy
US6110139A (en) * 1997-10-21 2000-08-29 Loubser; Paul Gerhard Retrograde perfusion monitoring and control system
EP1023058A2 (de) * 1997-10-24 2000-08-02 Alliance Pharmaceutical Corp. Verbesserung ischemiebedingter lesionen durch synthetische sauerstoffträger
US6679859B1 (en) 1997-10-24 2004-01-20 Alliance Pharmaceutical Corp. Amelioration of ischemic damage using synthetic oxygen carriers
US6712802B1 (en) * 1997-11-04 2004-03-30 Charles B. Cairns Metabolic therapy directed at electron transport
DE19861012A1 (de) 1998-03-18 1999-09-30 Pharm Pur Gmbh Behandlungsmittel für die Ophthalmologie
US6682551B1 (en) 1999-03-11 2004-01-27 Alsius Corporation Method and system for treating cardiac arrest using hypothermia
US6338727B1 (en) 1998-08-13 2002-01-15 Alsius Corporation Indwelling heat exchange catheter and method of using same
US6146411A (en) 1998-12-24 2000-11-14 Alsius Corporation Cooling system for indwelling heat exchange catheter
US6447500B1 (en) 2000-04-28 2002-09-10 Medtronic, Inc. Brain fluid ion concentration modification for treating neurological disorders
US20040073099A1 (en) * 2000-04-28 2004-04-15 Medtronic, Inc. Brain fluid ion concentration modification for treating neurological disorders
US6689756B2 (en) 2001-03-02 2004-02-10 Integra Lifesciences Corporation Treatment of neurological disease
US7278984B2 (en) * 2002-12-31 2007-10-09 Alsius Corporation System and method for controlling rate of heat exchange with patient
US7004961B2 (en) * 2003-01-09 2006-02-28 Edward Wong Medical device and method for temperature control and treatment of the brain and spinal cord
WO2007064927A2 (en) 2005-12-01 2007-06-07 Michigan Critical Care Consultants, Inc. Pulsatile rotary ventricular pump
EP2320968B1 (de) 2008-08-05 2012-05-09 Michigan Critical Care Consultants, Inc. Gerät und verfahren zur überwachung und kontrolle des extrakorporalen blutflusses relativ zum flüssigkeitsstatus eines patienten
EP2396549B1 (de) * 2009-02-12 2019-10-23 MC3, Inc. Modulare flüssigkeitspumpe mit patrone
WO2013165473A1 (en) * 2012-05-01 2013-11-07 Therox, Inc. System and method for bubble-free gas-enrichment of flowing liquid within a conduit
WO2022181126A1 (ja) * 2021-02-26 2022-09-01 テルモ株式会社 脳血管障害治療デバイス

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3482575A (en) * 1967-02-16 1969-12-09 Single Cell Research Foundatio Method for the extracorporeal oxygenation of blood
US3516410A (en) * 1968-01-03 1970-06-23 Salomon Hakim Cerebro-ventricular catheter
US3583387A (en) * 1968-12-20 1971-06-08 John T Garner Pressure absorbing appliance for treating hydrocephalus
US3626950A (en) * 1970-06-19 1971-12-14 Heyer Schulte Corp Catheter with augmented drainage means
US3669116A (en) * 1970-07-06 1972-06-13 Heyer Schulte Corp Drainage catheter with anticlogging means
US3669094A (en) * 1970-07-06 1972-06-13 Heyer Schulte Corp Device and method for measuring intracranial pressure
US3690323A (en) * 1970-12-01 1972-09-12 Us Army Device for draining ventricular fluid in cases of hydrocephalus
US3946731A (en) * 1971-01-20 1976-03-30 Lichtenstein Eric Stefan Apparatus for extracorporeal treatment of blood
US3753865A (en) * 1971-03-12 1973-08-21 Univ California Method and apparatus for preserving human organs extracorporeally
US3823091A (en) * 1971-05-19 1974-07-09 Green Cross Corp Stable emulsion of fluorocarbon particles
SE393537B (sv) * 1973-07-20 1977-05-16 Stille Werner Ab Anordning for inforande och styrning av en kateter eller liknande i haligheter eller blodkerl i kroppen pa en patient
FR2249657B1 (de) * 1973-11-07 1977-04-15 Ugine Kuhlmann
US3894541A (en) * 1974-02-27 1975-07-15 El Shafei Ismail Lotfy Method of treating hydrocephalus
US4163734A (en) * 1975-05-30 1979-08-07 Radiometer A/S Reference liquid for blood gas equipment
US4148314A (en) * 1976-10-18 1979-04-10 Baxter Travenol Laboratories, Inc. Blood pressure alarm system for dialysis machines
US4173654A (en) * 1977-01-03 1979-11-06 California Institute Of Technology Novel fluorohydrocarbons
US4173224A (en) * 1977-06-02 1979-11-06 Alvin J. Marx Automated intravenous fluid regulating and administering apparatus
US4110474A (en) * 1977-08-26 1978-08-29 Suntech, Inc. Tetramethylpentane blood substitutes
US4378797A (en) * 1980-04-14 1983-04-05 Thomas Jefferson University Extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders

Also Published As

Publication number Publication date
CA1188944A (en) 1985-06-18
EP0088954B1 (de) 1987-06-24
US4445886A (en) 1984-05-01
ATE27917T1 (de) 1987-07-15
JPS58185163A (ja) 1983-10-28
EP0088954A2 (de) 1983-09-21
EP0088954A3 (en) 1984-02-22

Similar Documents

Publication Publication Date Title
DE3372176D1 (en) Apparatus for use in stroke treatment utilizing extravascular circulation of oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
ZA812310B (en) Oxygenated synthetic nutrients to treat tissue hypoxic and ischemic disorders
Ryle et al. Cognitive-analytic therapy: Active participation in change: A new integration in brief psychotherapy.
Guerrien et al. Enhancement of memory by auditory stimulation during postlearning REM sleep in humans
Marsh et al. rHuEPO treatment improves brain and cognitive function of anemic dialysis patients
GR3018764T3 (en) System for the closed-loop administration of an exercise simulating agent.
AU5785290A (en) Cerebral and lumbar perfusion catheterization apparatus for use in treating hypoxic/ischemic neurologic tissue
GB8920228D0 (en) Fatty acid therapy
Bolger Cognitive retraining: A developmental approach.
Murray Effects of alone and audience on motor performance for males and females.
JPS51118841A (en) A drug for improving and treating clouding of consciousness
GB8816184D0 (en) Arrangement for regulating speed of circulation of fabric through treatment apparatus
Mathew et al. Anxiety and serum prolactin.
SU1392700A1 (ru) Способ лечени больных инфарктом миокарда
Sherwood et al. The effects of temporal uncertainty and response magnitude on cardiovascular adjustments during a reaction time task
Haslerud Anticipative transfer of mechanically guided turns.
Gandevia A human factor in ‘good’experiments
Ahuja Home based treatment of obsessive-compulsive disorder by behavioural technique.
Smith Muscle activity in relation to stuttering
Rangaswamy et al. Treatment of tension headache by progressive muscle relaxation.
Widén Quantitative measurements of regional brain metabolism during mental activity
Smith et al. The development of stuttering: Theoretical framework and preliminary data
Psatta EEG and clinical survey during biofeedback treatment of epileptics.
UONO et al. Histochemical Studies on the Disorders of Muscle Report 1. Phosphorylase, Succinic Dehydrogenase and Cholinesterase Activity in the Atrophied Muscle after Denervation
Coil SIXTH SYMPOSIUM ON THE INTERNATIONAL SOCIETY FOR VETERINARY EPIDEMIOLOGY AND ECONOMICS

Legal Events

Date Code Title Description
8364 No opposition during term of opposition